- Ipamorelin
-
- $1.00 / 1kg
-
2024-07-25
- CAS:170851-70-4
- Min. Order: 1kg
- Purity: 98%
- Supply Ability: 300tons
- Ipamorelin
-
- $17.00/ Box
-
2024-07-25
- CAS:170851-70-4
- Min. Order: 1Box
- Purity: 99.9%
- Supply Ability: 20000box
- Ipamorelin
-
- $0.00 / 1G
-
2024-07-25
- CAS:170851-70-4
- Min. Order: 1G
- Purity: 99%
- Supply Ability: 20
Related articles - The introduction of Ipamorelin
- Ipamorelin is a new and potent synthetic pentapeptide with distinct and specific growth hormone (GH)--releasing properties.
- Jun 17，2024
|
| | Ipamorelin Basic information |
| Product Name: | Ipamorelin | | Synonyms: | IpoMarelin;IPAMORELIN(1MG);IPAMORELIN(5MG);2-Methylalanyl-L-histidyl-3-(2-naphthyl)-D-alanyl-D-phenylalanyl-L-lysinamide;L-Lysinamide,2-methylalanyl-L-histidyl-3-(2-naphthalenyl)-D-alanyl-D-phenylalanyl-;NNC-26-0161;ipamorelin peptide powder;Peptides 5mg ipamorelin | | CAS: | 170851-70-4 | | MF: | C38H49N9O5 | | MW: | 711.85 | | EINECS: | 227-005-2 | | Product Categories: | Peptides;170851-70-4 | | Mol File: | 170851-70-4.mol |  |
| | Ipamorelin Chemical Properties |
| Melting point | 144-147°C | | Boiling point | 1185.5±65.0 °C(Predicted) | | density | 1.263±0.06 g/cm3(Predicted) | | storage temp. | -20°C Freezer | | solubility | Acetonitrile (Slightly, Heated), Methanol (Very Slightly), Water (Slightly) | | pka | 13.04±0.46(Predicted) | | form | Solid | | color | White to Off-White | | InChIKey | NEHWBYHLYZGBNO-BVEPWEIPSA-N | | SMILES | C(N)(=O)[C@H](CCCCN)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](CC1=CC=C2C(=C1)C=CC=C2)NC(=O)[C@H](CC1N=CNC=1)NC(=O)[C@](C)(C)N |
| | Ipamorelin Usage And Synthesis |
| Description | Ipamorelin (INN) (developmental code name NNC 26-0161) is a peptide selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS) and a growth hormone secretagogue.It is a pentapeptide with the amino acid sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2 that was derived from GHRP-1. | | Uses | Ipamorelin is a metabolite of growth hormone releasing peptides (GHRPs). Ipamorelin is a pentapeptide with strong growth hormone releasing potency that evokes insulin release from pancrease of normal and diabetic rats. | | Uses | Ipamorelin was originally developed by Novo Nordisk, and was investigated in phase II clinical trials by Helsinn Therapeutics for the treatment of postoperative ileus, but was discontinued due to lack of efficacy.Ipamorelin has been used by athletes as a performance enhancing drug. | | benefits | Ipamorelin has a wide range of benefits for the human body such as: reduced body fat, increased collagen production, increased lean muscle mass, improved sleep, increased cell repair and regeneration, elevated IGF-1, increased bone mineral content, counteracted glucocorticoid catabolism, decreased appetite stimulation compared to GHRP-6, decreased release of cortisol, prolactin and aldosterone.
Decreased release of cortisol, prolactin and aldosterone. | | Side effects |
Ipamorelin is generally considered safe and well tolerated, with common side effects including dizziness, headache, nausea, diarrhoea and flushing. Allergic or serious adverse reactions are rare. |
| | Ipamorelin Preparation Products And Raw materials |
|